Picture of Axsome Therapeutics logo

AXSM — Axsome Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Axsome's depression treatment fails to meet main goal of late-stage study

April 1 (Reuters) - Axsome Therapeutics AXSM.O said on Tuesday its experimental drug to treat major depressive disorder failed to meet the main goal of a late-stage study.

 (Reporting by Mariam Sunny in Bengaluru; Editing by Leroy Leo)

 ((Mariam.ESunny@thomsonreuters.com;))

Recent news on Axsome Therapeutics

See all news